인댑터스 테라퓨틱스(INDP)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.07 (+0.94%), 시가총액 $0.00B, 52주 범위 $0.27 ~ $12.87.
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
인댑터스 테라퓨틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
인댑터스 테라퓨틱스의 현재 주가는 $1.07 (+0.94%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
인댑터스 테라퓨틱스의 시가총액은 약 $0.00B입니다.
Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20,